文献速递眼底病与葡萄膜炎小儿眼科与斜弱视

美国单侧视网膜母细胞瘤初次眼球摘除后转移与死亡率(2007-2017)

Metastases and death rates after primary enucleation of unilateral retinoblastoma in the USA 2007-2017.
PubMed 文献 · Br J Ophthalmol · 2018-10-25

该研究回顾了美国五家三级视网膜母细胞瘤中心2007至2017年间接受初次眼球摘除的单侧视网膜母细胞瘤患者228例(228眼),随访超过1年或至治疗失败。结果发现转移9例(3.9%)、死亡4例(1.7%),5年无转移生存率为96%(95%CI 94%-99%),总生存率为98%(95%CI 96%-100%)。所有转移均在12个月内出现,多数转移患者具有高危病理特征。

要点

  • 单侧视网膜母细胞瘤初次眼球摘除后转移率3.9%、死亡率1.7%,5年无转移生存率96%。
  • 所有转移均在眼球摘除后12个月内出现,初始转移多表现为眶内侵犯(7/9)。
  • 高危病理(筛板后视神经侵犯和/或大面积脉络膜侵犯)见于27%(62/228)患眼。

核心结论

  • 单侧视网膜母细胞瘤初次眼球摘除后转移性死亡率低,但仍有3.9%的概率在摘除后一年内发生转移。
  • 发生转移的大多数但非全部患者具有高危组织病理学发现。

研究设计与样本

  • 回顾性图表审查,纳入美国五家三级视网膜母细胞瘤中心2007-2017年接受初次眼球摘除的单侧视网膜母细胞瘤患者228例(228眼),随访超过1年或至治疗失败。

主要发现

  • 228例中发生转移9例(3.9%),死亡4例(1.7%)。
  • 5年无转移生存率的Kaplan-Meier估计为96%(95%CI 94%-99%),总生存率为98%(95%CI 96%-100%)。
  • 所有转移均在12个月内出现。
  • 高危病理(筛板后视神经侵犯和/或大面积脉络膜侵犯)见于62/228眼(27%)。
  • 9例转移患者中7例(78%)具有高危病理;所有转移患者均为Reese-Ellsworth V期和International Classification of Retinoblastoma D或E组;初始转移表现为眶内侵犯者7/9例。

关键数值与推荐

  • 高危病理定义为筛板后视神经侵犯和/或大面积脉络膜侵犯,见于62/228眼(27%)。
  • 高危病理眼中39眼接受了辅助化疗,该组后续发生转移4例、死亡3例。

临床怎么用

  • 单侧视网膜母细胞瘤初次眼球摘除后需在一年内密切监测转移,尤其关注眶内侵犯表现。
  • 高危组织病理学发现(筛板后视神经侵犯和/或大面积脉络膜侵犯)应提示加强全身监测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND/AIMS: Enucleation for retinoblastoma is performed less often in the past decade due to increasingly widespread alternative therapies, but enucleation remains an important option. There is a paucity of reports on the current incidence of metastases and metastatic deaths in unilateral retinoblastoma from US centres. METHODS: Retrospective chart review at five tertiary retinoblastoma centres in the USA for unilateral retinoblastoma patients treated with primary enucleation, 2007-2017, with >1 year of follow-up or treatment failure. RESULTS: Among 228 patients (228 eyes), there were nine metastases (3.9%) and four deaths (1.7%). The Kaplan-Meier estimate at 5 years for metastasis-free survival was 96% (95% CI, 94% to 99 %), and for overall survival was 98% (95% CI 96% to 100%). All metastases were evident within 12 months. Histopathology revealed higher risk pathology (postlaminar optic nerve and/or massive choroidal invasion) in 62 of 228 eyes (27%). Of these higher risk eyes, 39 received adjuvant chemotherapy. There were four subsequent metastases in this higher risk pathology with adjuvant chemotherapy group, with three deaths. Of the nine overall with metastases, seven (78%) showed higher risk pathology. All metastatic patients were classified as Reese-Ellsworth V and International Classification of Retinoblastoma Groups D or E. Initial metastases presented as orbital invasion in seven of nine cases. CONCLUSIONS: Primary enucleation for unilateral retinoblastoma results in a low rate of metastatic death, but is still associated with a 3.9% chance of metastases within a year of enucleation. Most but not all patients who developed metastases had higher risk histopathological findings.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Lu JE, Francis JH, Dunkel IJ, et al. Metastases and death rates after primary enucleation of unilateral retinoblastoma in the USA 2007-2017. Br J Ophthalmol. 2018. PMID: 30361279. doi:10.1136/bjophthalmol-2018-312915

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。